Variant report

Variant	nsv1025555
Chromosome Location	chr9:16022186-16064158
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr9:16030527-16030923	GM12878	blood:	n/a	n/a
2	ATF2	chr9:16060647-16061176	GM12878	blood:	n/a	n/a
3	ATF2	chr9:16060750-16061133	GM12878	blood:	n/a	n/a
4	ATF3	chr9:16062761-16063303	A549	lung:	n/a	n/a
5	ATF3	chr9:16062908-16063301	HCT-116	colon:	n/a	n/a
6	ATF3	chr9:16062763-16063305	HCT-116	colon:	n/a	n/a
7	BATF	chr9:16062567-16062863	GM12878	blood:	n/a	n/a
8	BATF	chr9:16030503-16030837	GM12878	blood:	n/a	chr9:16030712-16030722
9	BATF	chr9:16046711-16046966	GM12878	blood:	n/a	n/a
10	BATF	chr9:16030529-16030841	GM12878	blood:	n/a	chr9:16030712-16030722
11	BATF	chr9:16060743-16061148	GM12878	blood:	n/a	n/a
12	BCL11A	chr9:16060792-16061149	GM12878	blood:	n/a	n/a
13	BCL11A	chr9:16030563-16030805	GM12878	blood:	n/a	chr9:16030711-16030720
14	BCL11A	chr9:16030497-16030868	GM12878	blood:	n/a	chr9:16030711-16030720
15	BHLHE40	chr9:16060676-16061037	GM12878	blood:	n/a	n/a
16	BHLHE40	chr9:16030533-16030834	GM12878	blood:	n/a	n/a
17	CBX3	chr9:16062787-16063294	HCT-116	colon:	n/a	n/a
18	CBX3	chr9:16030498-16031118	HCT-116	colon:	n/a	n/a
19	CBX3	chr9:16030378-16031078	HCT-116	colon:	n/a	n/a
20	CEBPB	chr9:16049017-16049349	A549	lung:	n/a	chr9:16049185-16049196
21	CEBPB	chr9:16025738-16026208	HepG2	liver:	n/a	chr9:16025870-16025881
22	CEBPB	chr9:16062761-16063670	A549	lung:	n/a	chr9:16063449-16063466 chr9:16063016-16063027 chr9:16063450-16063461 chr9:16063450-16063463 chr9:16063450-16063461
23	CEBPB	chr9:16062812-16063626	IMR90	lung:	n/a	chr9:16063449-16063466 chr9:16063016-16063027 chr9:16063450-16063461 chr9:16063450-16063463 chr9:16063450-16063461
24	CEBPB	chr9:16049018-16049283	Hela-S3	cervix:	n/a	chr9:16049185-16049196
25	CEBPB	chr9:16062813-16063608	Hela-S3	cervix:	n/a	chr9:16063449-16063466 chr9:16063016-16063027 chr9:16063450-16063461 chr9:16063450-16063463 chr9:16063450-16063461
26	CEBPB	chr9:16049057-16049343	HepG2	liver:	n/a	chr9:16049185-16049196
27	CEBPB	chr9:16058124-16058404	IMR90	lung:	n/a	n/a
28	CEBPB	chr9:16062757-16063382	HCT-116	colon:	n/a	chr9:16063016-16063027
29	CEBPB	chr9:16053308-16053347	A549	lung:	n/a	n/a
30	CEBPB	chr9:16025734-16026185	IMR90	lung:	n/a	chr9:16025870-16025881
31	CEBPB	chr9:16029202-16029509	IMR90	lung:	n/a	n/a
32	CEBPB	chr9:16062698-16063381	HCT-116	colon:	n/a	chr9:16063016-16063027
33	CEBPB	chr9:16025750-16026221	A549	lung:	n/a	chr9:16025870-16025881
34	CEBPB	chr9:16062695-16063727	A549	lung:	n/a	chr9:16063449-16063466 chr9:16063016-16063027 chr9:16063450-16063461 chr9:16063450-16063463 chr9:16063450-16063461
35	CEBPB	chr9:16040364-16040850	ECC-1	luminal epithelium:	n/a	n/a
36	CEBPB	chr9:16062769-16063273	MCF-7	breast:	n/a	chr9:16063016-16063027
37	CEBPB	chr9:16053187-16053402	HepG2	liver:	n/a	chr9:16053306-16053317
38	CEBPB	chr9:16049066-16049267	IMR90	lung:	n/a	chr9:16049185-16049196
39	CEBPB	chr9:16062861-16063167	HepG2	liver:	n/a	chr9:16063016-16063027
40	CEBPB	chr9:16026885-16027334	IMR90	lung:	n/a	n/a
41	CEBPB	chr9:16062837-16063527	A549	lung:	n/a	chr9:16063449-16063466 chr9:16063016-16063027 chr9:16063450-16063461 chr9:16063450-16063463 chr9:16063450-16063461
42	CHD2	chr9:16062868-16063231	Hela-S3	cervix:	n/a	n/a
43	CHD2	chr9:16030674-16030777	GM12878	blood:	n/a	n/a
44	CHD2	chr9:16040292-16040680	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTBP2	chr9:16040059-16040654	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr9:16039460-16039610	AG04450	lung:	n/a	n/a
47	CTCF	chr9:16039520-16039670	GM12873	blood:	n/a	n/a
48	CTCF	chr9:16039516-16039632	LNCaP	prostate:	n/a	n/a
49	CTCF	chr9:16033020-16033170	HRPEpiC	eye:	n/a	n/a
50	CTCF	chr9:16039461-16039693	MCF-7	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16039921-16039971	HRE	kidney:	n/a
2	chr9:16039921-16039971	HRE	kidney:	n/a
3	chr9:16040625-16040675	HUVEC	blood vessel:	n/a
4	chr9:16044344-16044394	AG04450	lung:	fetal
5	chr9:16044344-16044394	SAEC	small airway:	n/a
6	chr9:16040625-16040675	PFSK-1	brain:	n/a
7	chr9:16044344-16044394	IMR90	lung:	fetal
8	chr9:16044344-16044394	AG09319	gingival:	n/a
9	chr9:16040625-16040675	GM06990	blood:	n/a
10	chr9:16040625-16040675	NH-A	brain:	n/a
11	chr9:16040625-16040675	AoSMC	blood vessel:	n/a
12	chr9:16040625-16040675	HIPEpiC	eye:	n/a
13	chr9:16039921-16039971	HNPCEpiC	eye:	n/a
14	chr9:16039921-16039971	U87	brain:	n/a
15	chr9:16044344-16044394	AoSMC	blood vessel:	n/a
16	chr9:16044344-16044394	NB4	blood:	n/a
17	chr9:16044344-16044394	HCF	heart:	n/a
18	chr9:16039921-16039971	GM12891	blood:	n/a
19	chr9:16040625-16040675	NHDF-neo	bronchial:	n/a
20	chr9:16039921-16039971	Hepatocyte	liver:	n/a
21	chr9:16040625-16040675	BJ	skin:	n/a
22	chr9:16039921-16039971	AG09319	gingival:	n/a
23	chr9:16039921-16039971	MCF-7	breast:	n/a
24	chr9:16044344-16044394	K562	blood:	n/a
25	chr9:16044344-16044394	HEEpiC	esophagus:	n/a
26	chr9:16039921-16039971	PFSK-1	brain:	n/a
27	chr9:16040625-16040675	HEEpiC	esophagus:	n/a
28	chr9:16039921-16039971	AG04450	lung:	fetal
29	chr9:16039921-16039971	HCF	heart:	n/a
30	chr9:16044344-16044394	HL-60	blood:	n/a
31	chr9:16044344-16044394	HRPEpiC	eye:	n/a
32	chr9:16040625-16040675	LNCaP	prostate:	n/a
33	chr9:16039921-16039971	SKMC	muscle:	n/a
34	chr9:16040625-16040675	HMEC	breast:	n/a
35	chr9:16044344-16044394	A549	lung:	n/a
36	chr9:16040625-16040675	SK-N-SH_RA	brain:	n/a
37	chr9:16040625-16040675	AG04450	lung:	fetal
38	chr9:16039921-16039971	K562	blood:	n/a
39	chr9:16044344-16044394	CMK	blood:	n/a
40	chr9:16039921-16039971	HUVEC	blood vessel:	n/a
41	chr9:16044344-16044394	RPTEC	kidney:	n/a
42	chr9:16039921-16039971	SK-N-SH	brain:	n/a
43	chr9:16039921-16039971	GM12892	blood:	n/a
44	chr9:16040625-16040675	AG09309	skin:	n/a
45	chr9:16039921-16039971	HRCEpiC	kidney:	n/a
46	chr9:16039921-16039971	NT2-D1	testis:	n/a
47	chr9:16044344-16044394	BJ	skin:	n/a
48	chr9:16040625-16040675	PANC-1	pancreas:	n/a
49	chr9:16040625-16040675	MCF-7	breast:	n/a
50	chr9:16039921-16039971	Caco-2	colon:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:16032565..16033224-chr9:16133403..16134072,3	MCF-7	breast:
2	chr9:16032646..16033464-chr9:16130747..16131983,3	MCF-7	breast:
3	chr9:16063712..16066364-chr9:16092575..16094646,2	MCF-7	breast:
4	chr9:16039283..16040078-chr9:16131109..16131609,2	MCF-7	breast:
5	chr9:16039127..16039773-chr9:16131360..16131916,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SNAPC3-1	chr9:16042796-16042918	NONHSAT130279
2	lnc-SNAPC3-1	chr9:16035455-16035523	NONHSAT130279
3	lnc-SNAPC3-1	chr9:16060644-16061661	NONHSAT130279
4	lnc-SNAPC3-1	chr9:16036091-16036204	XLOC_007290
5	lnc-SNAPC3-1	chr9:16022737-16022906	NONHSAT130279
6	lnc-SNAPC3-1	chr9:16060644-16060851	XLOC_007290
7	lnc-SNAPC3-1	chr9:16042796-16042918	XLOC_007290
8	lnc-SNAPC3-1	chr9:16060644-16061855	XLOC_007290
9	lnc-SNAPC3-1	chr9:16035383-16035523	XLOC_007290
10	lnc-SNAPC3-1	chr9:16036091-16036204	XLOC_007290
11	lnc-SNAPC3-1	chr9:16036091-16036204	NONHSAT130279
12	lnc-SNAPC3-1	chr9:16022330-16022583	NONHSAT130279
13	lnc-SNAPC3-1	chr9:16060644-16061318	NONHSAT130282
14	lnc-SNAPC3-1	chr9:16042796-16042918	XLOC_007290
15	lnc-SNAPC3-1	chr9:16042796-16042884	NONHSAT130282

Variant related genes	Relation type
CCDC171	TF binding region
CCDC171	CpG island
CDC42EP3	miRNA target sites
PEMT	miRNA target sites
DACT1	miRNA target sites
MLL3	miRNA target sites
RAB6A	miRNA target sites

Extended variants
information (count: 1840 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:1840 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3124458	chr9:16022186-16022187	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs547061011	chr9:16022214-16022215	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs535602339	chr9:16022232-16022233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs13289131	chr9:16022240-16022241	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs13289132	chr9:16022241-16022242	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs141931776	chr9:16022267-16022268	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs575780708	chr9:16022316-16022317	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs193077141	chr9:16022333-16022334	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
9	rs564457081	chr9:16022352-16022353	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs56375073	chr9:16022369-16022370	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs146343707	chr9:16022441-16022442	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
12	rs184656380	chr9:16022444-16022445	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs562185779	chr9:16022446-16022447	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs529500048	chr9:16022515-16022516	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs2987077	chr9:16022527-16022528	Enhancers Weak transcription Strong transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs540490040	chr9:16022538-16022539	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
17	rs563067438	chr9:16022549-16022550	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
18	rs16933965	chr9:16022561-16022562	Enhancers Weak transcription Strong transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs370939375	chr9:16022564-16022565	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs551792383	chr9:16022630-16022631	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs188977950	chr9:16022631-16022632	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs181507633	chr9:16022634-16022635	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs546879426	chr9:16022723-16022724	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs78404950	chr9:16022742-16022743	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
25	rs113103515	chr9:16022791-16022792	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
26	rs55920240	chr9:16022805-16022806	Enhancers Weak transcription Strong transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs569408603	chr9:16022815-16022816	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
28	rs569040231	chr9:16022816-16022817	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs139315934	chr9:16022820-16022821	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs377725257	chr9:16022822-16022823	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs113164338	chr9:16022871-16022872	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs540223325	chr9:16022874-16022875	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs77529034	chr9:16022887-16022888	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs574225657	chr9:16022888-16022889	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
35	rs544421148	chr9:16022891-16022892	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
36	rs562729443	chr9:16022892-16022893	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
37	rs530549741	chr9:16022905-16022906	Enhancers Weak transcription Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
38	rs16933967	chr9:16022910-16022911	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs376317226	chr9:16022943-16022944	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs115629520	chr9:16023004-16023005	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs144044486	chr9:16023013-16023014	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs116216077	chr9:16023027-16023028	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs568359487	chr9:16023028-16023029	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs376160657	chr9:16023067-16023068	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs554339412	chr9:16023098-16023099	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs529186264	chr9:16023103-16023104	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs2987078	chr9:16023114-16023115	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs552030659	chr9:16023128-16023129	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs569071864	chr9:16023130-16023131	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs373148993	chr9:16023155-16023156	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21611746	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	19835627	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:502 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16018200-16028600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr9:16018400-16022400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr9:16019600-16022400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
4	chr9:16019800-16024400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr9:16022200-16022600	Enhancers	H1 Cell Line	embryonic stem cell
6	chr9:16022200-16022800	Enhancers	iPS-18 Cell Line	embryonic stem cell
7	chr9:16022200-16022800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr9:16022400-16022600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr9:16022400-16022600	Enhancers	NHLF	lung
10	chr9:16022400-16023000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr9:16022400-16023000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr9:16022400-16023600	Strong transcription	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr9:16022400-16024200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr9:16022400-16024800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr9:16022600-16023400	Enhancers	Muscle Satellite Cultured Cells	--
16	chr9:16022600-16023600	Weak transcription	NHLF	lung
17	chr9:16022600-16031800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr9:16022800-16024200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr9:16022800-16024600	Enhancers	NH-A	brain
20	chr9:16022800-16024800	Enhancers	NHDF-Ad	bronchial
21	chr9:16022800-16024800	Enhancers	Osteobl	bone
22	chr9:16023000-16024000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
23	chr9:16023000-16026200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr9:16023400-16023600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
25	chr9:16023400-16023800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr9:16023400-16024200	Enhancers	HMEC	breast
27	chr9:16023400-16024200	Enhancers	HSMM	muscle
28	chr9:16023600-16023800	Enhancers	Muscle Satellite Cultured Cells	--
29	chr9:16023600-16024200	Enhancers	NHLF	lung
30	chr9:16023600-16024400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr9:16023600-16040600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr9:16023800-16024000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
33	chr9:16023800-16025800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr9:16024000-16024200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr9:16024000-16024800	Enhancers	Muscle Satellite Cultured Cells	--
36	chr9:16024200-16024600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr9:16024200-16026000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr9:16024200-16027000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr9:16024200-16028200	Weak transcription	NHLF	lung
40	chr9:16024200-16028600	Weak transcription	HMEC	breast
41	chr9:16024400-16024800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr9:16024600-16024800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr9:16024600-16027000	Weak transcription	NH-A	brain
44	chr9:16024800-16026000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr9:16024800-16026000	Weak transcription	Osteobl	bone
46	chr9:16024800-16026400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr9:16024800-16027000	Weak transcription	Muscle Satellite Cultured Cells	--
48	chr9:16024800-16027000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
49	chr9:16024800-16027800	Weak transcription	NHDF-Ad	bronchial
50	chr9:16025400-16026200	Enhancers	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links